Cargando…

FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation

OBJECTIVES: Besides CD4 regulatory T-cells (Tregs), immunosuppressor FoxP3(+) CD8 T-cells are emerging as an important subset of Tregs, which contribute to immune dysfunction and disease progression in HIV infection. However, FoxP3(+) CD8 T-cell dynamics in acute HIV infection and following early an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yero, Alexis, Shi, Tao, Routy, Jean-Pierre, Tremblay, Cécile, Durand, Madeleine, Costiniuk, Cecilia T., Jenabian, Mohammad-Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372390/
https://www.ncbi.nlm.nih.gov/pubmed/35967314
http://dx.doi.org/10.3389/fimmu.2022.962912
_version_ 1784767370921771008
author Yero, Alexis
Shi, Tao
Routy, Jean-Pierre
Tremblay, Cécile
Durand, Madeleine
Costiniuk, Cecilia T.
Jenabian, Mohammad-Ali
author_facet Yero, Alexis
Shi, Tao
Routy, Jean-Pierre
Tremblay, Cécile
Durand, Madeleine
Costiniuk, Cecilia T.
Jenabian, Mohammad-Ali
author_sort Yero, Alexis
collection PubMed
description OBJECTIVES: Besides CD4 regulatory T-cells (Tregs), immunosuppressor FoxP3(+) CD8 T-cells are emerging as an important subset of Tregs, which contribute to immune dysfunction and disease progression in HIV infection. However, FoxP3(+) CD8 T-cell dynamics in acute HIV infection and following early antiretroviral therapy (ART) initiation remain understudied. METHODS: Subsets of FoxP3(+) CD8 T-cells were characterized both prospectively and cross-sectionally in PBMCs from untreated acute (n=26) and chronic (n=10) HIV-infected individuals, early ART-treated in acute infection (n=10, median of ART initiation: 5.5 months post-infection), ART-treated in chronic infection (n=10), elite controllers (n=18), and HIV-uninfected controls (n=21). RESULTS: Acute and chronic infection were associated with increased total, effector memory, and terminally differentiated FoxP3(+) CD8 T-cells, while early ART normalized only the frequencies of total FoxP3(+) CD8 T-cells. We observed an increase in FoxP3(+) CD8 T-cell immune activation (HLADR(+)/CD38(+)), senescence (CD57(+)/CD28(-)), and PD-1 expression during acute and chronic infection, which were not normalized by early ART. FoxP3(+) CD8 T-cells in untreated participants expressed higher levels of immunosuppressive LAP(TGF-β1) and CD39 than uninfected controls, whereas early ART did not affect their expression. The expression of gut-homing markers CCR9 and Integrin-β7 by total FoxP3(+) CD8 T-cells and CD39(+) and LAP(TGF-β1)(+) FoxP3(+) CD8 T-cells increased in untreated individuals and remained higher than in uninfected controls despite early ART. Elite controllers share most of the FoxP3(+) CD8 T-cell characteristics in uninfected individuals. CONCLUSIONS: Although early ART normalized total FoxP3(+) CD8 T-cells frequencies, it did not affect the persistent elevation of the gut-homing potential of CD39(+) and LAP(TGF-β1)(+) FoxP3(+) CD8 T-cell, which may contribute to immune dysfunction.
format Online
Article
Text
id pubmed-9372390
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93723902022-08-13 FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation Yero, Alexis Shi, Tao Routy, Jean-Pierre Tremblay, Cécile Durand, Madeleine Costiniuk, Cecilia T. Jenabian, Mohammad-Ali Front Immunol Immunology OBJECTIVES: Besides CD4 regulatory T-cells (Tregs), immunosuppressor FoxP3(+) CD8 T-cells are emerging as an important subset of Tregs, which contribute to immune dysfunction and disease progression in HIV infection. However, FoxP3(+) CD8 T-cell dynamics in acute HIV infection and following early antiretroviral therapy (ART) initiation remain understudied. METHODS: Subsets of FoxP3(+) CD8 T-cells were characterized both prospectively and cross-sectionally in PBMCs from untreated acute (n=26) and chronic (n=10) HIV-infected individuals, early ART-treated in acute infection (n=10, median of ART initiation: 5.5 months post-infection), ART-treated in chronic infection (n=10), elite controllers (n=18), and HIV-uninfected controls (n=21). RESULTS: Acute and chronic infection were associated with increased total, effector memory, and terminally differentiated FoxP3(+) CD8 T-cells, while early ART normalized only the frequencies of total FoxP3(+) CD8 T-cells. We observed an increase in FoxP3(+) CD8 T-cell immune activation (HLADR(+)/CD38(+)), senescence (CD57(+)/CD28(-)), and PD-1 expression during acute and chronic infection, which were not normalized by early ART. FoxP3(+) CD8 T-cells in untreated participants expressed higher levels of immunosuppressive LAP(TGF-β1) and CD39 than uninfected controls, whereas early ART did not affect their expression. The expression of gut-homing markers CCR9 and Integrin-β7 by total FoxP3(+) CD8 T-cells and CD39(+) and LAP(TGF-β1)(+) FoxP3(+) CD8 T-cells increased in untreated individuals and remained higher than in uninfected controls despite early ART. Elite controllers share most of the FoxP3(+) CD8 T-cell characteristics in uninfected individuals. CONCLUSIONS: Although early ART normalized total FoxP3(+) CD8 T-cells frequencies, it did not affect the persistent elevation of the gut-homing potential of CD39(+) and LAP(TGF-β1)(+) FoxP3(+) CD8 T-cell, which may contribute to immune dysfunction. Frontiers Media S.A. 2022-07-29 /pmc/articles/PMC9372390/ /pubmed/35967314 http://dx.doi.org/10.3389/fimmu.2022.962912 Text en Copyright © 2022 Yero, Shi, Routy, Tremblay, Durand, Costiniuk and Jenabian https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Yero, Alexis
Shi, Tao
Routy, Jean-Pierre
Tremblay, Cécile
Durand, Madeleine
Costiniuk, Cecilia T.
Jenabian, Mohammad-Ali
FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
title FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
title_full FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
title_fullStr FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
title_full_unstemmed FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
title_short FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
title_sort foxp3(+) cd8 t-cells in acute hiv infection and following early antiretroviral therapy initiation
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372390/
https://www.ncbi.nlm.nih.gov/pubmed/35967314
http://dx.doi.org/10.3389/fimmu.2022.962912
work_keys_str_mv AT yeroalexis foxp3cd8tcellsinacutehivinfectionandfollowingearlyantiretroviraltherapyinitiation
AT shitao foxp3cd8tcellsinacutehivinfectionandfollowingearlyantiretroviraltherapyinitiation
AT routyjeanpierre foxp3cd8tcellsinacutehivinfectionandfollowingearlyantiretroviraltherapyinitiation
AT tremblaycecile foxp3cd8tcellsinacutehivinfectionandfollowingearlyantiretroviraltherapyinitiation
AT durandmadeleine foxp3cd8tcellsinacutehivinfectionandfollowingearlyantiretroviraltherapyinitiation
AT costiniukceciliat foxp3cd8tcellsinacutehivinfectionandfollowingearlyantiretroviraltherapyinitiation
AT jenabianmohammadali foxp3cd8tcellsinacutehivinfectionandfollowingearlyantiretroviraltherapyinitiation